Evidence map›Paper›PMID 36103556›Full record

ArticlePLoS pathogens2022

Strengthening of enterococcal biofilms by Esp.

Lindsey Spiegelman, Adrian Bahn-Suh, Elizabeth T Montaño, Ling Zhang, Greg L Hura, Kathryn A Patras, Amit Kumar, F Akif Tezcan, Victor Nizet, Susan E Tsutakawa and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Multidrug-ResistantVeterinary sciences · 2025
    Article
  6. Article
  7. Review
  8. Isolation ofAntibiotics (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Enterococci,Microorganisms · 2024
    Article
  11. Review
  12. Structural and biochemical characterization ofProcess biochemistry (Barking, London, England) · 2023
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lindsey SpiegelmanDepartment of Chemistry & Biochemistry, University of California, San Diego, La Jolla, California, United States of America.
Adrian Bahn-SuhDepartment of Chemistry & Biochemistry, University of California, San Diego, La Jolla, California, United States of America.
Elizabeth T MontañoDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California, San Diego, La Jolla, California, United States of America.
Ling ZhangDepartment of Chemistry & Biochemistry, University of California, San Diego, La Jolla, California, United States of America.
Greg L HuraMolecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America.
Kathryn A PatrasDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California, San Diego, La Jolla, California, United States of America.
Amit KumarDepartment of Chemistry & Biochemistry, University of California, San Diego, La Jolla, California, United States of America.
F Akif TezcanDepartment of Chemistry & Biochemistry, University of California, San Diego, La Jolla, California, United States of America.
Victor NizetDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California, San Diego, La Jolla, California, United States of America.
Susan E TsutakawaMolecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America.
Partho GhoshDepartment of Chemistry & Biochemistry, University of California, San Diego, La Jolla, California, United States of America.ORCID 0000-0003-0254-5218
University of California San Diego · USLawrence Berkeley National Laboratory · US

Funding

User Training and OutreachP30GM124169 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PAUL David ADAMS · 2017 to 2026
$28.6M
UCSD/SDSU IRACDAK12GM068524 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2003 to 2025
$24.4M
GENETIC MECHANISMS AND REGULATIONT32GM007240 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HAMPTON, RANDOLPH Y. · 1985 to 2019
$23.8M
Overall Priority Score P41GM103694 · NIGMS · EMORY UNIVERSITY · PI CUMMINGS, RICHARD D · 2013 to 2018
$6.9M
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)R24GM137763 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI RICHARD D CUMMINGS · 2020 to 2026
$5.8M
Evasion of host immunity by the M proteinR01AI154149 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PARTHO · 2020 to 2024
$3.2M
Towards Accurate Protein Structure Predictions with SAXS Technology (TAPESTRY)R01GM137021 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI TSUTAKAWA, SUSAN EMIKO · 2020 to 2023
$1.6M
Mechanisms of the M protein in group A Streptococcus virulenceR56AI096837 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PARTHO, NIZET, VICTOR · 2018 to 2018
$540k
Acquisition of a High Resolution TOF Mass SpectrometerS10RR025636 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MOLINSKI, TADEUSZ F · 2010 to 2010
$305k
NCRR NIH HHS S10 RR025636NIAID NIH HHS R01 AI154149NIAID NIH HHS R56 AI096837NIGMS NIH HHS P30 GM124169NIGMS NIH HHS P41 GM103694NIGMS NIH HHS R01 GM137021NIGMS NIH HHS R24 GM137763NIGMS NIH HHS T32 GM007240
6 · The paper itself

Abstract

Multidrug-resistant (MDR) Enterococcus faecalis are major causes of hospital-acquired infections. Numerous clinical strains of E. faecalis harbor a large pathogenicity island that encodes enterococcal surface protein (Esp), which is suggested to promote biofilm production and virulence, but this remains controversial. To resolve this issue, we characterized the Esp N-terminal region, the portion implicated in biofilm production. Small angle X-ray scattering indicated that the N-terminal region had a globular head, which consisted of two DEv-Ig domains as visualized by X-ray crystallography, followed by an extended tail. The N-terminal region was not required for biofilm production but instead significantly strengthened biofilms against mechanical or degradative disruption, greatly increasing retention of Enterococcus within biofilms. Biofilm strengthening required low pH, which resulted in Esp unfolding, aggregating, and forming amyloid-like structures. The pH threshold for biofilm strengthening depended on protein stability. A truncated fragment of the first DEv-Ig domain, plausibly generated by a host protease, was the least stable and sufficient to strengthen biofilms at pH ≤ 5.0, while the entire N-terminal region and intact Esp on the enterococcal surface was more stable and required a pH ≤ 4.3. These results suggested a virulence role of Esp in strengthening enterococcal biofilms in acidic abiotic or host environments.

Indexed as

Gram-Positive Bacterial InfectionsMembrane ProteinsBacterial ProteinsBiofilmsEnterococcusEnterococcus faecalisHumansPeptide HydrolasesBacterial ProteinsMembrane ProteinsPeptide Hydrolases

Identifiers

PMID36103556
PMCPMC9512215
OpenAlexW4295706187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.